http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2175375-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb5549b815e80cfffb3f9f84b99324db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46efb3dcc7564d78c81e62a7b66b939f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H13-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H13-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04
filingDate 1994-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6facff571284ea58a037a144e29d8902
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94b653180465936de2935b0fb228dba5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef346f561fbd43ebdd0337a7caa0fd0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_175de3c87bb96e05c36850e542d3a0c6
publicationDate 1995-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2175375-A1
titleOfInvention Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use
abstract The invention relates to .beta.(16) glucosamine disaccharides having general formula (I) to a method for preparing these disaccharides, comprising the steps of: i) providing a starting material comprising lipid A moiety of lipopolysaccharide-comprising microorganisms; and ii) subjecting the starting material to an alkaline treatment such that lipid A moiety is O-deacylated at the 3-position and at the 3'-position, to pharmaceutical compositions comprising as an active ingredient these disaccharides, and to these disaccharides for use as an immunomodulating agent, anti-tumor agent, and vaccine component.
priorityDate 1993-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407295578
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514403
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3893
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25200834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119228

Total number of triples: 43.